Wikidata

(Q64187728)

English

A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis

clinical trial

In more languages

Statements

short name
CONSONANCE (English)
0 references
title
An Open-Label, Single-Arm 4-Year Study to Evaluate Effectiveness and Safety of Ocrelizumab Treatment in Patients With Progressive Multiple Sclerosis (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
sponsor
Hoffmann-La Roche
0 references
country
Algeria
0 references
Bosnia and Herzegovina
0 references
Brazil
0 references
Canada
0 references
Colombia
0 references
Costa Rica
0 references
Denmark
0 references
Egypt
0 references
France
0 references
Guatemala
0 references
Hungary
0 references
Republic of Ireland
0 references
Italy
0 references
Lebanon
0 references
Mexico
0 references
Morocco
0 references
Netherlands
0 references
Panama
0 references
Poland
0 references
Saudi Arabia
0 references
Spain
0 references
United Arab Emirates
0 references
start time
28 May 2018
0 references
end time
29 September 2023
0 references
number of participants
600
0 references
minimum age
18 year
0 references
maximum age
65 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64187728&oldid=1857609103"